Pages that link to "Q40766940"

The following pages link to The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C. (Q40766940):

Displaying 11 items.

• Targeting Protein Kinase C Downstream of Growth Factor and Adhesion Signalling (Q26799902) (← links)
• The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells (Q27313466) (← links)
• The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study (Q34570826) (← links)
• Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family (Q35816817) (← links)
• Enzastaurin, an inhibitor of PKCbeta, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells (Q36970534) (← links)
• Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia (Q37644988) (← links)
• PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells (Q39924786) (← links)
• Involvement of PKC-iota in glioma proliferation (Q40022122) (← links)
• Effects of the PKC inhibitor PD 406976 on cell cycle progression, proliferation, PKC isozymes and apoptosis in glioma and SVG-transformed glial cells (Q40432925) (← links)
• Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro (Q40643553) (← links)
• The membrane targeted apoptosis modulators erucylphosphocholine and erucylphosphohomocholine increase the radiation response of human glioblastoma cell lines in vitro (Q42414110) (← links)